Europe’s leadership in life sciences needs strong frameworks and partnerships

Studio Politico and Ricardo Marek

No csf6m, OSF Preprints from Center for Open Science

Abstract: POLITICO Studio speaks with Ricardo Marek, President Europe and Canada at Takeda Pharmaceuticals, on why rare diseases need to be a public health priority, and how Europe can remain a leader in life sciences.

Date: 2022-10-29
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://osf.io/download/6365fc22e9045b0c510427c7/

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:osf:osfxxx:csf6m

DOI: 10.31219/osf.io/csf6m

Access Statistics for this paper

More papers in OSF Preprints from Center for Open Science
Bibliographic data for series maintained by OSF ().